Australia markets closed

AEON Biopharma, Inc. (AEON)

NYSE American - NYSE American Delayed price. Currency in USD
Add to watchlist
1.5500+0.1600 (+11.51%)
At close: 04:00PM EDT
1.4200 -0.13 (-8.39%)
Pre-market: 07:35AM EDT
Show:
Income statement
Balance sheet
Annual

Cash flow

All numbers in thousands
Breakdown
ttm
31/12/2022
31/12/2021
31/12/2020
31/12/2019
Cash flows from operating activities
Net income
-
-52,556
-55,637
-32,913
172,920
Depreciation & amortisation
-
68
3
0
1,258
Deferred income taxes
-
-
-
0
-14,645
Stock-based compensation
-
5,892
5,220
4,793
5,252
Change in working capital
-
6,268
1,416
1,452
50
Accounts receivable
-
-
-
-148
-24
Inventory
-
-
-
0
-7,393
Accounts payable
-
6,613
-898
667
3,924
Other working capital
-
-35,890
-28,603
-9,461
-46,419
Other non-cash items
-
4,413
18,587
5,483
14,956
Net cash provided by operating activities
-
-35,584
-28,433
-9,461
-44,725
Cash flows from investing activities
Investments in property, plant and equipment
-
-306
-170
-
-1,694
Acquisitions, net
-
-
-
-1,265
-36,529
Purchases of investments
-
-
-
0
-89,068
Sales/maturities of investments
-
-
-
0
10,000
Net cash used for investing activities
-
-306
-170
-1,265
-117,291
Cash flows from financing activities
Debt repayment
-
-3,992
0
-300
-74,228
Common stock issued
-
-
-
0
77,795
Common stock repurchased
-
-
-
0
-64
Other financing activities
-
-
-1,437
-541
-14,196
Net cash used provided by (used for) financing activities
-
40,508
13,563
24,570
73,213
Net change in cash
-
4,618
-15,040
13,844
-88,803
Cash at beginning of period
-
5,128
20,168
6,324
95,127
Cash at end of period
-
9,746
5,128
20,168
6,324
Free cash flow
Operating cash flow
-
-35,584
-28,433
-9,461
-44,725
Capital expenditure
-
-306
-170
-
-1,694
Free cash flow
-
-35,890
-28,603
-9,461
-46,419